ADMA Biologics CEO Adam Grossman's 2023 pay jumps 128% to $6M
ADMA Biologics reports 2023 executive compensation
By ExecPay News
Published: April 15, 2024
ADMA Biologics reported fiscal year 2023 executive compensation information on April 15, 2024.
In 2023, two executives at ADMA Biologics received on average a compensation package of $4M, a 88% increase compared to previous year.
Average pay of disclosed executives at ADMA Biologics
Adam S. Grossman, Chief Executive Officer, received $6M in total, which increased by 128% compared to 2022. 42% of Grossman's compensation, or $2.5M, was in option awards. Grossman also received $793K in bonus, $750K in salary, $1.9M in stock awards, as well as $47K in other compensation.
Brian Lenz, Chief Financial Officer, received a compensation package of $2M, which increased by 23% compared to previous year. 30% of the compensation package, or $596K, was in option awards.
Related executives
You may also like
Source: SEC filing on April 15, 2024.